SCHEMBL6771827

SCHEMBL6771827

COc1cccc(-n2nc(CC(C)C)c3c2CC(C)CC3=O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.37
CSNK2A2 P19784 2/20 0.37
CSNK2B P67870 2/20 0.37
CSNK2A1 P68400 2/20 0.37
CSNK2A3 Q8NEV1 1/20 0.37
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
RAB9A P51151 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
SRC P12931 1/20 0.36
RIPK2 O43353 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6772551 0.89 DHODH (0.37) HPGDSMN1; SMN2RAB9AL3MBTL1MEN1
SCHEMBL6772144 0.88 RIPK2 (0.36) ABCG2CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL6766537 0.86 ALDH1A1 (0.41) ABCG2HPGDSMN1; SMN2RAB9AL3MBTL1
SCHEMBL6167949 0.86 ABCG2 (0.44) ABCG2CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL6775862 0.84 ABCG2 (0.39) ABCG2CSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL6772063 0.83 OPRM1 (0.48) SMN1; SMN2RAB9AL3MBTL1MEN1NPC1
SCHEMBL6769419 0.83 SRC (0.47) ABCG2CSNK2A2CSNK2BCSNK2A1SMN1; SMN2
SCHEMBL6766708 0.82 RIPK2 (0.48) HPGDSMN1; SMN2RAB9AL3MBTL1MEN1
SCHEMBL6769486 0.81 OPRM1 (0.55) SRC
SCHEMBL6772323 0.81 GPBAR1 (0.41) HPGDSMN1; SMN2RAB9AL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed